Blackstone Group »

Harpoon Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Harpoon Therapeutics shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Harpoon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Harpoon Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harpoon Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.3M 815k 11.37

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Energy Transfer Com Ut Ltd Ptn (ET)
Corebridge Finl (CRBG)
Gates Indl Corp Ord Shs (GTES)
FirstEnergy (FE)
Chesapeake Energy Corp (CHK)
Cheniere Energy Com New (LNG)
PG&E Corporation (PCG)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Bumble Com Cl A (BMBL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Western Midstream Partners L Com Unit Lp Int (WES)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)

View all positions for Blackstone Group

Top funds holding Harpoon Therapeutics

Cormorant Asset Management
Commodore Capital
RA Capital Management
Franklin Resources
Artal Group
Vanguard Group
Soleus Capital Management
Blackstone Group
Citadel Advisors
Lion Point Capital
Kennedy Capital Management
Goldman Sachs Group
Citigroup
Two Sigma Investments
Standard Life Aberdeen

View all funds holding Harpoon Therapeutics